Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression

Abstract Background NOSTRIN, abundantly expressed in colon, was reported to be anti-angiogenic, anti-invasive and anti-inflammatory. NOSTRIN expression was inversely related to survival of pancreatic ductal adeno-carcinoma patients. Yet its function and regulatory mechanism in CRC remains elusive. M...

Full description

Bibliographic Details
Main Authors: Madhurima Paul, Tamal Kanti Gope, Priyanka Das, Rupasri Ain
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-022-09670-6
_version_ 1811257318077104128
author Madhurima Paul
Tamal Kanti Gope
Priyanka Das
Rupasri Ain
author_facet Madhurima Paul
Tamal Kanti Gope
Priyanka Das
Rupasri Ain
author_sort Madhurima Paul
collection DOAJ
description Abstract Background NOSTRIN, abundantly expressed in colon, was reported to be anti-angiogenic, anti-invasive and anti-inflammatory. NOSTRIN expression was inversely related to survival of pancreatic ductal adeno-carcinoma patients. Yet its function and regulatory mechanism in CRC remains elusive. Methods NOSTRIN’s influence on EMT of CRC cells were analysed using realtime PCR array containing the functional EMT-transcriptome followed by western blotting. Regulation of oncogenic potential of CRC cells by NOSTRIN was elucidated using soft agar colony formation, trans-well invasion, wound healing and colonosphere formation assays. Biochemical assays were used to reveal mechanism of NOSTRIN function. Human CRC tissue array was used to test NOSTRIN mark in control and CRC disease stages. Results We showed here that CRC cell lines with less NOSTRIN expression has more invasive and migratory potential. NOSTRIN affected EMT-associated transcriptome of CRC cells by down regulating 33 genes that were functionally annotated to transcription factors, genes important for cell growth, proliferation, migration, cell adhesion and cytoskeleton regulators in CRC cells. NOSTRIN over-expression significantly reduced soft agar colony formation, wound healing and cell invasion. In line with this, RNA interference of Nostrin enhanced metastatic potential of CRC cells. Furthermore, stable overexpression of NOSTRIN in CRC cell line not only curtailed its ability to form colonosphere but also decreased expression of stemness markers CD133, CD44 and EpCAM. NOSTRIN’s role in inhibiting self-renewal was further confirmed using BrdU incorporation assay. Interestingly, NOSTRIN formed immune-complex with Cdk1 in CRC cells and aided in increase of inhibitory Y15 and T14 phosphorylation of Cdk1 that halts cytokinesis. These ex vivo findings were substantiated using human colon cancer tissue array containing cDNAs from patients’ samples with various stages of disease progression. Significant decrease in NOSTRIN expression was found with initiation and progression of advanced colon cancer disease stages. Conclusion We illustrate function of a novel molecule, NOSTRIN in curtailing EMT and maintenance of CRC cell stemness. Our data validates importance of NOSTRIN mark during onset and disease progression of CRC indicating its diagnostic potential.
first_indexed 2024-04-12T17:55:28Z
format Article
id doaj.art-49b16a616ed34e7886b45c9a63ce8b42
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-12T17:55:28Z
publishDate 2022-05-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-49b16a616ed34e7886b45c9a63ce8b422022-12-22T03:22:22ZengBMCBMC Cancer1471-24072022-05-0122112010.1186/s12885-022-09670-6Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progressionMadhurima Paul0Tamal Kanti Gope1Priyanka Das2Rupasri Ain3Division of Cell Biology and Physiology, CSIR-Indian Institute of Chemical BiologyDivision of Cell Biology and Physiology, CSIR-Indian Institute of Chemical BiologyDivision of Cell Biology and Physiology, CSIR-Indian Institute of Chemical BiologyDivision of Cell Biology and Physiology, CSIR-Indian Institute of Chemical BiologyAbstract Background NOSTRIN, abundantly expressed in colon, was reported to be anti-angiogenic, anti-invasive and anti-inflammatory. NOSTRIN expression was inversely related to survival of pancreatic ductal adeno-carcinoma patients. Yet its function and regulatory mechanism in CRC remains elusive. Methods NOSTRIN’s influence on EMT of CRC cells were analysed using realtime PCR array containing the functional EMT-transcriptome followed by western blotting. Regulation of oncogenic potential of CRC cells by NOSTRIN was elucidated using soft agar colony formation, trans-well invasion, wound healing and colonosphere formation assays. Biochemical assays were used to reveal mechanism of NOSTRIN function. Human CRC tissue array was used to test NOSTRIN mark in control and CRC disease stages. Results We showed here that CRC cell lines with less NOSTRIN expression has more invasive and migratory potential. NOSTRIN affected EMT-associated transcriptome of CRC cells by down regulating 33 genes that were functionally annotated to transcription factors, genes important for cell growth, proliferation, migration, cell adhesion and cytoskeleton regulators in CRC cells. NOSTRIN over-expression significantly reduced soft agar colony formation, wound healing and cell invasion. In line with this, RNA interference of Nostrin enhanced metastatic potential of CRC cells. Furthermore, stable overexpression of NOSTRIN in CRC cell line not only curtailed its ability to form colonosphere but also decreased expression of stemness markers CD133, CD44 and EpCAM. NOSTRIN’s role in inhibiting self-renewal was further confirmed using BrdU incorporation assay. Interestingly, NOSTRIN formed immune-complex with Cdk1 in CRC cells and aided in increase of inhibitory Y15 and T14 phosphorylation of Cdk1 that halts cytokinesis. These ex vivo findings were substantiated using human colon cancer tissue array containing cDNAs from patients’ samples with various stages of disease progression. Significant decrease in NOSTRIN expression was found with initiation and progression of advanced colon cancer disease stages. Conclusion We illustrate function of a novel molecule, NOSTRIN in curtailing EMT and maintenance of CRC cell stemness. Our data validates importance of NOSTRIN mark during onset and disease progression of CRC indicating its diagnostic potential.https://doi.org/10.1186/s12885-022-09670-6EMTCancer stem cellColonosphereColorectal cancerPrognostic markerHCT116
spellingShingle Madhurima Paul
Tamal Kanti Gope
Priyanka Das
Rupasri Ain
Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression
BMC Cancer
EMT
Cancer stem cell
Colonosphere
Colorectal cancer
Prognostic marker
HCT116
title Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression
title_full Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression
title_fullStr Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression
title_full_unstemmed Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression
title_short Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression
title_sort nitric oxide synthase trafficking inducer nostrin is an emerging negative regulator of colon cancer progression
topic EMT
Cancer stem cell
Colonosphere
Colorectal cancer
Prognostic marker
HCT116
url https://doi.org/10.1186/s12885-022-09670-6
work_keys_str_mv AT madhurimapaul nitricoxidesynthasetraffickinginducernostrinisanemergingnegativeregulatorofcoloncancerprogression
AT tamalkantigope nitricoxidesynthasetraffickinginducernostrinisanemergingnegativeregulatorofcoloncancerprogression
AT priyankadas nitricoxidesynthasetraffickinginducernostrinisanemergingnegativeregulatorofcoloncancerprogression
AT rupasriain nitricoxidesynthasetraffickinginducernostrinisanemergingnegativeregulatorofcoloncancerprogression